Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Use of Venlafaxine in Reducing Pain in Primary Total Knee Replacement
Sponsor: University of California, San Francisco
Summary
Patients experience pain after their knee replacement surgery - and some may continue to experience persistent pain long after their knee replacement surgery. Traditional pain management strategies reply on pain medication such as opioids for pain control. However, these drugs do not work well for pain associated with movement or the the nerve pain (tingling, electrical sensations) after surgery. In addition, opioids are associated with significant side effects such as nausea, vomiting, respiratory depression, depression, cognitive dysfunction and risk of persistent opioid use. Neuropathic pain medications, such as venlafaxine are effective in managing nerve pain. Recent studies also support its potential role in acute pain management. Here, we propose a prospective randomized clinical trial 1) to evaluate the efficacy of Venlafaxine in reducing pain intensity and opioid consumption at post-operative day 1 (POD1) and 1- week after surgery, and 2) to examine whether the use of Venlafaxine will reduce the incidents of chronic postsurgical pain in TKA patients at 3-month time point.
Official title: The Use of Venlafaxine in Reducing Acute Post-Surgical Pain and Opioid Consumption in Primary Total Knee Replacement
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2021-05-10
Completion Date
2025-03-31
Last Updated
2026-11-10
Healthy Volunteers
Yes
Interventions
Venlafaxine 37.5 MG
venlafaxine 37.5mg daily for 7 consecutive days.
Placebo
placebo filled pill daily for 7 consecutive days.
Locations (1)
University of California San Francisco
San Francisco, California, United States